Shree Ram Proteins plans EGM for asset sale up to ₹30 Cr and ₹100 Cr QIP
Shree Ram Proteins Limited announced an EGM on March 5, 2026, to approve selling its undertaking for up to ₹30 crore to Sova Agrotech Private Limited. Additionally, the company plans to raise up to ₹100 crore via QIP for business growth. Remote e-voting is open from March 2-4, 2026.
The proposed sale of a significant portion of the company's undertaking, even if non-core, and the substantial ₹100 crore capital raise through QIP are material events that could impact the company's structure, financial health, and future growth trajectory. The related party aspect of the asset sale warrants careful consideration.
The announcement contains two significant proposals: an asset sale and a capital raise. While the asset sale involves a related party, the company states it's for monetizing non-core assets and improving liquidity. The capital raise is for growth. The overall sentiment is neutral as the benefits are balanced by the related party transaction and the need for capital.
Shree Ram Proteins Limited will hold an Extra Ordinary General Meeting (EGM) on Thursday, March 05, 2026, at 3:30 PM IST via Video Conference (VC) / Other Audio Visual Means (OAVM). The EGM will seek shareholder approval for two key proposals.
Firstly, the company proposes to sell, lease, or otherwise dispose of the whole or substantially the whole of its undertaking to Sova Agrotech Private Limited, a related party. This transaction is valued at a consideration not exceeding ₹30 crore and is intended to monetize non-core assets, improve liquidity, and strengthen the balance sheet. Ms. Geetaben Lalitbhai Vasoya, a promoter, is also a director in Sova Agrotech Private Limited, creating a direct/indirect interest in the transaction.
Secondly, the company plans to raise capital up to ₹100 crore through a Qualified Institutions Placement (QIP) of equity shares and/or other eligible securities. The proceeds from this issue will be used for business growth and expansion initiatives. The QIP is expected to be completed within 365 days from the passing of the resolution, and the allotment will be made to eligible Qualified Institutional Buyers (QIBs).
The remote e-voting facility will be available from Monday, March 02, 2026, at 10:00 AM IST until Wednesday, March 04, 2026, at 05:00 PM IST.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under egm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.